Mesalamine 66.7 MG/ML Enema — RxCUI 238151
RxNorm drug concept · Semantic clinical drug
RxCUI 238151
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
17 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI238151
Official nameMesalamine 66.7 MG/ML Enema
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmesalazine 66.7 MG/ML Enema; mesalamine 4 GM in 60 mL Enema; mesalamine 4 GM per 60 ML Enema
FDA products mapped12
Package NDCs mapped17
Reported Medicaid activity (SDUD)8,183 prescriptions · 30 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Mesalamine Rectal: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Mesalamine rectal works by calming the inflammation directly in the lining of your rectum and lower colon — the area affected by your condition. It blocks some of the chemical sign...
- What exactly is this medication doing for my colitis?
- Treatment is typically continued for 3 to 6 weeks depending on your symptoms and what your doctor sees during examination. It's important to keep using it for the full course your...
- How long do I need to use it before it starts working?
🕸️ Concept Web — How Mesalamine 66.7 MG/ML Enema Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Mesalamine 66.7 MG/ML Enema
RxCUI 238151 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Mesalamine
52582IN
-
Mesalamine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Rowasa
202834BN
-
Rowasa
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Mesalamine Enema
372785SCDF -
Mesalamine Rectal Product
1165716SCDG -
Mesalamine Enema [Rowasa]
94002SBDF -
Rowasa Rectal Product
1182568SBDG -
Enema
317678DF -
Rectal Product
1151127DFG
-
Mesalamine Enema
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Mesalamine 66.7 MG/ML
330724SCDC -
Mesalamine 66.7 MG/ML Enema [Rowasa]
206798SBD -
Mesalamine 66.7 MG/ML [Rowasa]
567607SBDC
-
Mesalamine 66.7 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Mesalamine 66.7 MG/ML
SCDC · 330724 -
Mesalamine Enema
SCDF · 372785 -
Mesalamine Rectal Product
SCDG · 1165716
Brand-Name Concepts
-
Mesalamine 66.7 MG/ML Enema [Rowasa]
SBD · 206798 -
Mesalamine 66.7 MG/ML [Rowasa]
SBDC · 567607 -
Mesalamine Enema [Rowasa]
SBDF · 94002 -
Rowasa Rectal Product
SBDG · 1182568 -
Rowasa
BN · 202834
📦 FDA Products & Package NDCs
12 products · 17 package NDCs
17 package NDCs map to RxCUI 238151 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00037-0022-07 | 7 BOTTLE, WITH APPLICATOR in 1 CARTON (0037-0022-07) / 60 m... | sfRowasa Sulfite-Free Formulation | Viatris Specialty LLC | 2016-03-24 |
| 00037-0022-28 | 28 BOTTLE, WITH APPLICATOR in 1 CARTON (0037-0022-28) / 60... | sfRowasa Sulfite-Free Formulation | Viatris Specialty LLC | 2016-05-24 |
| 00037-0066-03 | 28 BOTTLE, DISPENSING in 1 CARTON (0037-0066-03) / 60 mL in... | Rowasa | Viatris Specialty LLC | 2016-03-24 |
| 00037-0066-05 | 7 BOTTLE, DISPENSING in 1 CARTON (0037-0066-05) / 60 mL in... | Rowasa | Viatris Specialty LLC | 2016-03-24 |
| 21922-0045-47 | 7 BOTTLE, DISPENSING in 1 CARTON (21922-045-47) / 60 mL in... | Mesalamine | Encube Ethicals, Inc. | 2023-06-01 |
| 21922-0045-49 | 28 BOTTLE, DISPENSING in 1 CARTON (21922-045-49) / 60 mL in... | Mesalamine | Encube Ethicals, Inc. | 2023-06-01 |
| 45802-0098-28 | 28 BOTTLE in 1 CARTON (45802-098-28) / 60 mL in 1 BOTTLE | Mesalamine | Padagis Israel Pharmaceuticals Ltd | 2008-02-12 |
| 45802-0098-51 | 7 BOTTLE in 1 CARTON (45802-098-51) / 60 mL in 1 BOTTLE | Mesalamine | Padagis Israel Pharmaceuticals Ltd | 2007-10-11 |
| 45802-0923-41 | 1 KIT in 1 CARTON (45802-923-41) * 60 mL in 1 BOTTLE (4580... | Mesalamine | Padagis Israel Pharmaceuticals Ltd | 2009-09-01 |
| 45802-0929-49 | 4 CARTON in 1 KIT (45802-929-49) / 1 KIT in 1 CARTON * 60... | Mesalamine | Padagis Israel Pharmaceuticals Ltd | 2018-08-02 |
| 62559-0420-07 | 7 BOTTLE in 1 BOX (62559-420-07) / 60 mL in 1 BOTTLE (62559... | Mesalamine | ANI Pharmaceuticals, Inc. | 2016-05-13 |
| 63629-8678-01 | 1 KIT in 1 CARTON (63629-8678-1) * 60 mL in 1 BOTTLE (4580... | Mesalamine | Bryant Ranch Prepack | 2009-09-01 |
| 63629-8679-01 | 4 CARTON in 1 KIT (63629-8679-1) / 1 KIT in 1 CARTON * 60... | Mesalamine | Bryant Ranch Prepack | 2018-08-02 |
| 70954-0301-20 | 7 BOTTLE in 1 CARTON (70954-301-20) / 60 mL in 1 BOTTLE (70... | Mesalamine | ANI Pharmaceuticals, Inc. | 2026-05-14 |
| 72162-2302-02 | 7 BOTTLE, DISPENSING in 1 CARTON (72162-2302-2) / 60 mL in... | Mesalamine | Bryant Ranch Prepack | 2024-04-30 |
| 72162-2302-04 | 28 BOTTLE, DISPENSING in 1 CARTON (72162-2302-4) / 60 mL in... | Mesalamine | Bryant Ranch Prepack | 2024-04-30 |
| 84725-0002-03 | 7 BOTTLE in 1 CARTON (84725-002-03) / 60 mL in 1 BOTTLE | MESALAMINE | KLM Laboratories Private Limited | 2026-04-01 |
Observed labelers:
Bryant Ranch Prepack (4) ·
Padagis Israel Pharmaceuticals Ltd (4) ·
Viatris Specialty LLC (4) ·
ANI Pharmaceuticals, Inc. (2) ·
Encube Ethicals, Inc. (2) ·
KLM Laboratories Private Limited (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.